Related Experiment Video

Updated: Aug 27, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

632

[Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer]

Satoshi Muto1, Sho Inomata, Hikaru Yamaguchi

  • 1Dept. of Chest Surgery, Fukushima Medical University, School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 26, 2022
PubMed

Insights

The WNT/β-catenin pathway drives resistance to immune checkpoint inhibitors in lung cancer. Targeting this pathway offers a strategy to overcome immune escape and improve treatment efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Immune checkpoint inhibitors (ICIs) show promise but face challenges due to acquired resistance.
  • The WNT/β-catenin pathway is implicated in cancer progression and, more recently, in immune escape.
  • Understanding WNT/β-catenin's role in ICI resistance is crucial for advancing cancer therapy.

Purpose of the Study:

  • To review the involvement of the WNT/β-catenin pathway in immune escape and ICI resistance.
  • To focus on non-small cell lung cancer (NSCLC) as a primary model.
  • To discuss strategies for overcoming WNT/β-catenin-mediated immune suppression.

Main Methods:

  • Literature review of studies investigating the WNT/β-catenin pathway in cancer immunology.
  • Analysis of mechanisms linking WNT/β-catenin signaling to immune evasion in NSCLC.
  • Synthesis of current and emerging combination therapies targeting this pathway.

Main Results:

  • The WNT/β-catenin pathway contributes to immune suppression and resistance to ICIs in various cancers, including NSCLC.
  • This pathway influences the tumor microenvironment, hindering anti-tumor immune responses.
  • Evidence suggests targeting WNT/β-catenin can re-sensitize tumors to ICI therapy.

Conclusions:

  • The WNT/β-catenin pathway is a significant mechanism of resistance to immune checkpoint inhibitors, particularly in non-small cell lung cancer.
  • Overcoming WNT/β-catenin-driven immune escape requires novel therapeutic strategies, including combination therapies.
  • Targeting the WNT/β-catenin pathway holds potential for improving patient outcomes in ICI-treated cancers.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K